Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing risperidone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone measurement |
Component |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone poisoning |
Causative agent (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Accidental risperidone poisoning |
Causative agent (attribute) |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Intentional risperidone poisoning |
Causative agent (attribute) |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
intoxication par la rispéridone d'intention indéterminée |
Causative agent (attribute) |
False |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone adverse reaction |
Causative agent (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Allergy to risperidone |
Causative agent (attribute) |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Risperidone overdose |
Causative agent (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Accidental risperidone overdose |
Causative agent (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Intentional risperidone overdose |
Causative agent (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
surdose de rispéridone d'intention indéterminée |
Causative agent (attribute) |
False |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Risperidone 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Risperidone 3 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Risperidone 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Risperidone 6 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Product containing precisely risperidone 500 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Risperidone 1mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Risperidone 250 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Risperidone 1 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Risperidone depot 25mg powder+solvent for suspension for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Risperidone depot 37.5mg powder+solvent for suspension for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Risperidone depot 50mg powder+solvent for suspension for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Risperdal consta |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Risperdal consta 25mg powder+solvent for suspension for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Risperdal consta 37.5mg powder+solvent for suspension for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Risperdal consta 50mg powder+solvent for suspension for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Risperidone-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone 25mg powder+solvent for suspension for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Risperidone 37.5mg powder+solvent for suspension for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Risperidone 50mg powder+solvent for suspension for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Product containing precisely risperidone 1 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Product containing precisely risperidone 2 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Risperidone 0.25mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Risperidone 25mg powder+solvent for suspension for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Risperidone 37.5mg powder+solvent for suspension for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Risperidone 50mg powder+solvent for suspension for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Product containing precisely risperidone 500 microgram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Accidental risperidone poisoning |
Causative agent (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Intentional risperidone poisoning |
Causative agent (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone 12.5mg powder+solvent for suspension for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Product containing precisely risperidone 3 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Risperidone 4 mg orodispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Allergy to risperidone |
Causative agent (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone 1 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone 2 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone 3 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone 3 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone 4 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone 6 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone 6 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely risperidone 500 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely risperidone 500 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone 250 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone 250 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone 1 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone 2 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone 3 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone 4 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone 6 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely risperidone 500 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone 250 microgram oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone 12.5 mg powder for suspension for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Product containing precisely risperidone 25 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Product containing precisely risperidone 37.5 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Risperidone 50 mg powder for suspension for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Some |
|
Risperidone 1 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone 1 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Product containing only risperidone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely risperidone 2 milligram/1 each conventional release orodispersible tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely risperidone 2 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely risperidone 3 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely risperidone 3 milligram/1 each conventional release orodispersible tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely risperidone 500 microgram/1 each conventional release orodispersible tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely risperidone 500 microgram/1 each conventional release orodispersible tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone 4 mg orodispersible tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone 4 mg orodispersible tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely risperidone 1 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely risperidone 1 milligram/1 each conventional release orodispersible tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone 12.5 mg powder for suspension for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone 12.5 mg powder for suspension for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely risperidone 25 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely risperidone 25 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely risperidone 37.5 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely risperidone 37.5 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone 50 mg powder for suspension for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone 50 mg powder for suspension for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Product containing risperidone in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Product containing only risperidone in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone 25 mg powder for prolonged-release suspension for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone 25 mg powder for prolonged-release suspension for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely risperidone 37.5 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely risperidone 37.5 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |
Risperidone 50 mg powder for prolonged-release suspension for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Risperidone (substance) |
Inferred relationship |
Some |
1 |